Anson Funds Management LP Buys Shares of 95,100 Core Scientific, Inc. $CORZ

Key Points

• Anson Funds Management LP purchased **95,100 shares** of Core Scientific, Inc., valued at approximately **$689,000**, during the 1st quarter.
• The company reported a **44.3% decline** in revenue year-over-year, totaling **$78.63 million** for the last quarter, despite outperforming analyst EPS estimates.
• Analysts have a consensus rating of **"Hold"** on Core Scientific, with one **"Strong Buy"**, eight **"Buy"**, and eleven **"Hold"** ratings, alongside a price target average of **$18.39**.

Anson Funds Management LP purchased a new stake in shares of Core Scientific, Inc. (NASDAQ:CORZ - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 95,100 shares of the company's stock, valued at approximately $689,000.

A number of other large investors also recently bought and sold shares of the stock. Ameriprise Financial Inc. purchased a new stake in shares of Core Scientific in the 4th quarter valued at $2,950,000. BNP Paribas Financial Markets raised its position in Core Scientific by 57.2% in the 4th quarter. BNP Paribas Financial Markets now owns 241,456 shares of the company's stock valued at $3,392,000 after purchasing an additional 87,872 shares in the last quarter. Cresset Asset Management LLC lifted its stake in Core Scientific by 16.4% in the fourth quarter. Cresset Asset Management LLC now owns 35,668 shares of the company's stock worth $501,000 after acquiring an additional 5,022 shares during the last quarter. D. E. Shaw & Co. Inc. acquired a new position in Core Scientific during the 4th quarter worth approximately $9,774,000. Finally, Deutsche Bank AG increased its position in shares of Core Scientific by 53.8% in the 4th quarter. Deutsche Bank AG now owns 165,032 shares of the company's stock valued at $2,319,000 after purchasing an additional 57,742 shares during the last quarter.

Insider Activity at Core Scientific

In other news, insider Todd M. Duchene sold 7,759 shares of the company's stock in a transaction on Wednesday, June 25th. The stock was sold at an average price of $12.39, for a total transaction of $96,134.01. Following the completion of the sale, the insider directly owned 2,049,689 shares in the company, valued at $25,395,646.71. This represents a 0.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. 1.40% of the stock is currently owned by insiders.

Core Scientific Price Performance

Shares of CORZ stock opened at $15.99 on Thursday. The firm's 50-day simple moving average is $14.05 and its 200-day simple moving average is $11.25. Core Scientific, Inc. has a 1-year low of $6.20 and a 1-year high of $18.63. The firm has a market cap of $4.88 billion, a P/E ratio of -28.55 and a beta of 6.59.

Core Scientific (NASDAQ:CORZ - Get Free Report) last released its earnings results on Friday, August 8th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.03. The company had revenue of $78.63 million during the quarter, compared to analysts' expectations of $82.09 million. The business's revenue for the quarter was down 44.3% compared to the same quarter last year. Analysts expect that Core Scientific, Inc. will post 0.52 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Barclays downgraded Core Scientific to an "underweight" rating in a report on Tuesday, July 8th. JMP Securities reissued a "market perform" rating on shares of Core Scientific in a report on Tuesday, August 12th. Jefferies Financial Group boosted their price objective on shares of Core Scientific from $16.00 to $22.00 and gave the company a "buy" rating in a research note on Monday, August 18th. Roth Mkm reissued a "buy" rating and set a $20.00 target price on shares of Core Scientific in a research note on Thursday, June 26th. Finally, HC Wainwright reiterated a "neutral" rating on shares of Core Scientific in a research note on Monday, August 11th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Core Scientific has a consensus rating of "Hold" and a consensus price target of $18.39.

Core Scientific Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

Want to see what other hedge funds are holding CORZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Scientific, Inc. (NASDAQ:CORZ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.